.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Fish and Richardson
Baxter
Accenture
Chubb
Cipla
QuintilesIMS
Dow
Healthtrust
Julphar

Generated: January 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 98204447

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Janssen PharmsRAZADYNE ERgalantamine hydrobromideCAPSULE, EXTENDED RELEASE;ORAL021615-001Apr 1, 2005ABRXYesYes➤ Subscribe➤ SubscribeY
Janssen PharmsRAZADYNE ERgalantamine hydrobromideCAPSULE, EXTENDED RELEASE;ORAL021615-002Apr 1, 2005ABRXYesNo➤ Subscribe➤ SubscribeY
Janssen PharmsRAZADYNE ERgalantamine hydrobromideCAPSULE, EXTENDED RELEASE;ORAL021615-003Apr 1, 2005ABRXYesNo➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist